{"$schema":"https://fireballnews.com/?wal_manifest_schema=1","archiveEvidence":{"capturedAt":"2026-07-16T23:15:58+00:00","discoveryMethod":"availability","provider":{"name":"Internet Archive","url":"https://archive.org/"},"snapshotUrl":"https://web.archive.org/web/20260716231558/https://fireballnews.com/fda-advisors-overwhelmingly-recommend-alzheimers-drug-approval/","verificationMethod":"http-resolution","verificationStatus":"verified","verifiedAt":"2026-07-18T15:36:03+00:00"},"digests":[],"entryId":"urn:uuid:bdc222b7-259b-4d31-b0d0-95e2a02602dc","generator":{"name":"WP ContentLedger","version":"0.3.0"},"limitations":["Content and representation digests were not created retroactively for this pre-0.3.0 record."],"manifestVersion":"1.0","provenance":{"evidenceCapturedAt":"2026-07-16T21:58:25+00:00","legacyImported":true,"recordSource":"bulk"},"sealedAt":"2026-07-20T18:28:53+00:00","subject":{"canonicalUrl":"https://fireballnews.com/fda-advisors-overwhelmingly-recommend-alzheimers-drug-approval/","dateModified":"2025-06-08T18:42:59+00:00","datePublished":"2024-06-10T02:20:21+00:00","postType":"post","publisher":{"name":"Fireball News","url":"https://fireballnews.com/"},"title":"FDA Advisors Strongly Back New Alzheimer’s Drug, Despite Risks and Limitations","type":"WebPage"}}